Tag Archives: Bruker

  • Bruker

    Bruker Announces Acquisition of MERLIN Diagnostika GmbH

    Bruker has announced the completion of its acquisition of MERLIN Diagnostika GmbH, located near Bonn, Germany.  MERLIN has in-depth expertise in products, services and consulting in the fields of antibiotic resistance testing (ART) and antibiotic susceptibility testing (AST). Bruker claims that MERLIN’s technology and product portfolio will further expand thier microbiology business, which is based on […]

  • Bruker

    Bruker Reports Q1 2016 Financial Results

    Bruker’s revenues for the first quarter of 2016 were $375.4 million, an increase of 6.2 percent compared to revenues of $353.3 million in the first quarter of 2015.  Excluding a 1.5 percent net positive effect from acquisitions & divestitures, and a 0.9 percent negative effect from changes in foreign exchange rates, Bruker reported year-over-year organic […]

  • Bruker

    Bruker Reports Financial Results for Q1 2015

      Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2015. Bruker’s revenues for the first quarter of 2015 were $353.5 million, a decline of 16.6 percent compared to the first quarter of 2014. Excluding a 2.6 percent net negative effect from acquisitions & divestitures, and an 11.0 percent negative effect […]

  • Bruker Reports Q2 2013 Results

      Revenues for the second quarter of 2013 grew by 8.1 percent to $454.9 million, compared to$420.7 million in the second quarter of 2012. Excluding a 0.8 percent negative effect from changes in foreign exchange rates and a 0.6 percent net negative effect from acquisitions and divestitures, Bruker generated organic revenue growth of 9.5 percent in the second quarter […]

  • Bruker Reports Fourth Quarter and Full Year 2012 Results

    Revenues for the fourth quarter 2012 grew 8.9 percent to $517.3 million from $475.1 million in Q4 2011. Excluding a 2.1 percent negative effect from changes in foreign exchange rates and a 0.8 percent net contribution from acquisitions and divestitures, Bruker generated year-over-year organic revenue growth of approximately 10.2 percent in the fourth quarter of 2012. More…